Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy
- 2 June 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (11) , 2116-2123
- https://doi.org/10.1016/j.jacc.2003.12.051
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting ProteinHypertension, 2002
- Preactivated Peripheral Blood Monocytes in Patients With Essential HypertensionHypertension, 1999
- Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential HypertensionCirculation, 1998
- Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential HypertensionCirculation, 1996
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyNew England Journal of Medicine, 1994
- The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.Circulation Research, 1991
- Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential HypertensionAnnals of Internal Medicine, 1991
- Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.Circulation, 1991
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- The multifactorial role of catecholamines in hypertensive cardiac hypertrophyEuropean Heart Journal, 1982